Market Highlights It is estimated that the global Idiopathic Pulmonary Fibrosis (IPF) Treatment market Size is expected to register a CAGR of 12.3% during the forecast period of 2023 to 2030, with a market value of USD 2,237 million in 2030. IPF is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period. The IPF treatment...